The greatest loss of life from breast cancer occurs between the ages of 30 and 50. Fortunately, women today have more options available to them to help in the detection of breast cancer than in the past decades. Unfortunately, education and awareness of these options, and their effectiveness in detecting breast cancer at different stages in life, are woefully deficient.

Breast Thermography, or "MammoTherms," employ a heat-sensing scanner to detect variations in the temperature of breast tissue. The technology has been around since the 1960s, however, early infrared scanners were not very sensitive and they were insufficiently tested before being
put into clinical practice. This resulted in misdiagnosed cases.

Modern-day technology is vastly improved
and more extensive scientific clinical breast thermography research is available, with data from major peer review journals and research on more than 300,000 women who have been tested. It has been successful in detecting breast cancer more accurately than other methods, and the technology is also gaining ground among more progressive practitioners, such as the Health Medicine Center.

Breast thermography has demonstrated a higher degree of success
in identifying women with breast cancer under the age of 55 in comparison to other technologies, and it's also an effective adjunct to clinical breast exams and mammography for women over 55. Finally, it provides a non-invasive and safe detection method, and if introduced at age 25, provides a benchmark that future scans can be compared with for even greater detection accuracy.

This thermal imaging technology has been validated as effective and approved by the FDA for breast cancer risk assessment. Recent studies have documented that thermography, as a single test, has 99% accuracy in identifying breast cancer in women in the 30 to 55 age group. For women over 55 the accuracy is still an impressive 95%.